Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Topiramate Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Topiramate Manufacturers in India Suppliers Topiramate Dossage Exporters Distributors Topiramate api active pharmaceuticals ingredients Topiramate manufacturers Side Effects bulk drugs raw material Dossage Topiramate companies Side Effects Dossage Importers Topiramate Dossage Topiramate Exporters Topiramate exporters Dossage FDA Dossage Topiramate Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Topiramate manufacturing pharmaceutical drugs pharmaceutical intermediates Topiramate pharmaceutical chemicals pharmaceutical raw materials Topiramate active pharmaceutical ingredients Topiramate committee active pharmaceutical ingredients manufacturer Topiramate Active Pharmaceutical Ingredients manufacturer Topiramate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Topiramate, Topiramate manufacturer India, Topiramate product, Topiramate products, Api preparation, Certificate of Analysis API manufacturer product, Topiramate anti ulcer product, Certificate of Origin COA Topiramate COS Topiramate, pharmaceutical generic, pharmaceutical drug, medical, Topiramate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Topiramate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Topiramate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Topiramate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Topiramate ingredients, api, HIV Topiramate, tablets, capsules, syrup & protein Topiramate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Topiramate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Topiramate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image pharmblue



 

 








 

 

 

 

HOME >> API >> API List 3 >> Topiramate >> Dosage

Topiramate CAS Registry Number 97240-79-4

DOSAGE

Topiramate CAS Registry Number 97240-79-4


Most commonly, topiramate is started in low doses, 25 or 50 mg per day, and then increased slowly, under a doctor's orders, by 25 to 50 mg per week until an effective daily dose is reached. This slow approach to treatment reduces side effects.

In children, the starting dose is up to 25 mg (1 to 3 mg/kg/day), taken nightly for the first week. The dose is then increased at 1 or 2 week intervals by 1 to 3 mg/kg/day.

Although the usual adult dose is 200 mg twice daily, some adult patients may begin to see a clinical response at 200 mg per day. Some patients need doses higher than 200 mg daily. In children, the usual dose is 2.5 to 4.5 mg/kg twice daily.

Patients should maintain an adequate fluid intake in order to minimize the risk of kidney stones.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  



Taj Pharmaceuticals API Logo

Topiramate

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.